Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2402886
Max Phase: Preclinical
Molecular Formula: C16H12O3
Molecular Weight: 252.27
Molecule Type: Small molecule
Associated Items:
ID: ALA2402886
Max Phase: Preclinical
Molecular Formula: C16H12O3
Molecular Weight: 252.27
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=c1c(Cc2cccc(O)c2)coc2ccccc12
Standard InChI: InChI=1S/C16H12O3/c17-13-5-3-4-11(9-13)8-12-10-19-15-7-2-1-6-14(15)16(12)18/h1-7,9-10,17H,8H2
Standard InChI Key: RNZAJMBZBCMQJG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 252.27 | Molecular Weight (Monoisotopic): 252.0786 | AlogP: 3.09 | #Rotatable Bonds: 2 |
Polar Surface Area: 50.44 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.45 | CX Basic pKa: | CX LogP: 3.34 | CX LogD: 3.34 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.76 | Np Likeness Score: 0.51 |
1. Kupcewicz B, Balcerowska-Czerniak G, Małecka M, Paneth P, Krajewska U, Rozalski M.. (2013) Structure-cytotoxic activity relationship of 3-arylideneflavanone and chromanone (E,Z isomers) and 3-arylflavones., 23 (14): [PMID:23756061] [10.1016/j.bmcl.2013.05.044] |
Source(1):